Aixiang Jiang

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

Journal: Blood advances

Published: February 13, 2026

Gradient of CD79B expression in diffuse large B-cell lymphoma corresponds to stages of germinal center B-cell differentiation.

Gradient of CD79B expression in diffuse large B-cell lymphoma corresponds to stages of germinal center B-cell differentiation.

Journal: Haematologica

Published: November 18, 2025

Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy.

Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy.

Journal: Haematologica

Published: July 13, 2025

Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.

Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.

Journal: Blood advances

Published: May 28, 2025

Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes.

Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes.

Journal: Cancer discovery

Published: May 18, 2025

Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes.

Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes.

Journal: Cancer discovery

Published: May 18, 2025

Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq.

Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq.

Journal: Blood advances

Published: May 08, 2025

Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma.

Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma.

Journal: Blood

Published: January 16, 2025

Large B cell lymphoma microenvironment archetype profiles.

Large B cell lymphoma microenvironment archetype profiles.

Journal: Cancer cell

Published: November 15, 2024

MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma.

MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma.

Journal: Blood cancer journal

Published: July 24, 2024

CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL.

CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL.

Journal: Blood

Published: June 11, 2024

TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.

TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 25, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026